Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Tag: PMDA GMP (Japan)

How ANVISA GMP Regulations Influence the Production of Vaccines

Posted on December 31, 2024 By digi

How ANVISA GMP Regulations Influence the Production of Vaccines How ANVISA GMP Regulations Influence the Production of Vaccines Introduction to ANVISA and Vaccine Manufacturing Vaccines are one of the most important tools in global public health, preventing the spread of infectious diseases and saving millions of lives worldwide. The production of vaccines is a complex…

Read More “How ANVISA GMP Regulations Influence the Production of Vaccines” »

GMP in Latin America (ANVISA, COFEPRIS)

Best Practices for Preparing for TGA GMP Inspections and Audits

Posted on December 31, 2024 By digi

Best Practices for Preparing for TGA GMP Inspections and Audits Effective Strategies for TGA GMP Inspection and Audit Readiness Introduction to TGA GMP Inspections and Audits The Therapeutic Goods Administration (TGA) conducts rigorous Good Manufacturing Practices (GMP) inspections and audits to ensure that pharmaceutical companies comply with Australian quality, safety, and efficacy standards. These inspections…

Read More “Best Practices for Preparing for TGA GMP Inspections and Audits” »

TGA GMP Guidelines

How Schedule M (Revised) GMP Helps Prevent the Production of Counterfeit Drugs

Posted on December 31, 2024 By digi

How Schedule M (Revised) GMP Helps Prevent the Production of Counterfeit Drugs Preventing Counterfeit Drugs with Schedule M (Revised) GMP Guidelines Introduction to Counterfeit Drugs and Their Risks Counterfeit drugs pose a serious threat to public health and the pharmaceutical industry. These illegal products, which mimic legitimate medicines, often lack active ingredients, contain harmful substances,…

Read More “How Schedule M (Revised) GMP Helps Prevent the Production of Counterfeit Drugs” »

SCHEDULE - M - Revised

PMDA GMP Guidelines for the Manufacture of Biopharmaceutical Products

Posted on December 31, 2024 By digi

PMDA GMP Guidelines for the Manufacture of Biopharmaceutical Products PMDA GMP Guidelines for the Manufacture of Biopharmaceutical Products Introduction to PMDA GMP and Biopharmaceutical Manufacturing Biopharmaceutical products, including biologics, vaccines, and gene therapies, are becoming increasingly important in the treatment of a wide range of diseases. These products are often more complex to manufacture than…

Read More “PMDA GMP Guidelines for the Manufacture of Biopharmaceutical Products” »

PMDA GMP Guidelines

The Role of WHO GMP in Promoting Good Manufacturing Practices in Global Pharma

Posted on December 31, 2024 By digi

The Role of WHO GMP in Promoting Good Manufacturing Practices in Global Pharma Advancing Global Pharmaceutical Standards with WHO GMP Guidelines Introduction to WHO GMP and Its Global Impact The World Health Organization (WHO)’s Good Manufacturing Practices (GMP)) guidelines play a pivotal role in shaping the global pharmaceutical industry. By establishing standardized protocols for manufacturing,…

Read More “The Role of WHO GMP in Promoting Good Manufacturing Practices in Global Pharma” »

WHO GMP Guidelines

MHRA GMP Compliance and Its Impact on the UK Pharma Market

Posted on December 31, 2024 By digi

MHRA GMP Compliance and Its Impact on the UK Pharma Market The Role of MHRA GMP Compliance in Shaping the UK Pharmaceutical Market Introduction to MHRA GMP Compliance The United Kingdom’s pharmaceutical industry operates within one of the most stringent regulatory frameworks globally, with the Medicines and Healthcare products Regulatory Agency (MHRA) overseeing the enforcement…

Read More “MHRA GMP Compliance and Its Impact on the UK Pharma Market” »

MHRA GMP Guidelines

How NMPA GMP Promotes Drug Safety and Quality Control

Posted on December 30, 2024 By digi

How NMPA GMP Promotes Drug Safety and Quality Control How NMPA GMP Promotes Drug Safety and Quality Control Introduction to NMPA GMP and Drug Safety In the pharmaceutical industry, ensuring the safety and quality of drugs is paramount to protecting public health. The National Medical Products Administration (NMPA), formerly known as the China Food and…

Read More “How NMPA GMP Promotes Drug Safety and Quality Control” »

NMPA GMP Guidelines

TGA GMP and the Role of Technology in Pharmaceutical Manufacturing

Posted on December 30, 2024 By digi

TGA GMP and the Role of Technology in Pharmaceutical Manufacturing How Technology Enhances TGA GMP Compliance in Pharmaceutical Manufacturing Introduction to TGA GMP and Technology The Therapeutic Goods Administration (TGA) enforces Good Manufacturing Practices (GMP) in Australia to ensure the safety, quality, and efficacy of pharmaceutical products. As the pharmaceutical industry evolves, technology plays an…

Read More “TGA GMP and the Role of Technology in Pharmaceutical Manufacturing” »

TGA GMP Guidelines

How COFEPRIS GMP Ensures the Quality of Biological Drugs

Posted on December 30, 2024 By digi

How COFEPRIS GMP Ensures the Quality of Biological Drugs How COFEPRIS GMP Ensures the Quality of Biological Drugs Introduction to Biological Drugs and COFEPRIS GMP Biological drugs, also known as biologics, are a class of pharmaceuticals derived from living organisms or their components. These drugs, which include vaccines, monoclonal antibodies, gene therapies, and cell therapies,…

Read More “How COFEPRIS GMP Ensures the Quality of Biological Drugs” »

GMP in Latin America (ANVISA, COFEPRIS)

How WHO GMP Guidelines Ensure the Quality of Pharmaceutical Products in Africa

Posted on December 30, 2024 By digi

How WHO GMP Guidelines Ensure the Quality of Pharmaceutical Products in Africa Ensuring Pharmaceutical Quality in Africa with WHO GMP Guidelines Introduction to Pharmaceutical Quality and WHO GMP The quality of pharmaceutical products is essential for ensuring public health, especially in regions with diverse healthcare challenges like Africa. Substandard and counterfeit drugs pose significant risks…

Read More “How WHO GMP Guidelines Ensure the Quality of Pharmaceutical Products in Africa” »

WHO GMP Guidelines

Posts pagination

Previous 1 … 15 16 17 … 50 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme